The MarketWatch News Department was not involved in the creation of this content.-- Newly discovered drug leverages the power of Pattern Discovery Engine(TM) (PDE) and is an exten ...

Researchers from The University of Texas MD Anderson Cancer Center have found that simultaneously blocking two key "don't eat me signals" found in cancer cells heightens the immune response and ...

Despite decades of advancements in surgical techniques, chemotherapy, and radiotherapy, the clinical outlook for patients diagnosed with primary brain tumors remains sobering. Whi ...

Renowned cancer researcher Professor Richard Scolyer has shared an emotional update on his brain cancer, as he continues to ...

Virginia Commonwealth University (VCU) Massey Comprehensive Center has debuted a new first-in-market brachytherapy brain tumor surgery to treat glioblastoma, according to officials.

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential to significantly boost the immune system’s ability to ...

Phase 1 clinical trials evaluate the safety and dosage of proposed new treatments. Further research is needed to test the oncolytic virus therapy’s effectiveness and side effects. Work also continues ...

A modified herpes virus boosted immune T cell infiltration in glioblastoma tumors and was associated with improved survival.

Todd Willever was diagnosed in 2022 with a devastating brain cancer that doctors estimated would give him 10 to 15 months to ...

Honing in on four markers for effective, patient-specific devices to combat glioblastoma.

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...